{"filing": {"accession": "0001493152-26-041918", "cik": "0001847345", "ticker": "ASBP", "company_name": "Aspire Biopharma Holdings, Inc.", "form_type": "8-K", "filing_type": "8-K", "filing_date": "2026-09-09", "accepted_datetime": null, "acceptance_datetime": null, "accepted_at": null, "primary_doc_url": "https://www.sec.gov/Archives/edgar/data/1847345/000149315226041918/0001493152-26-041918-index.htm", "filing_url": "https://www.sec.gov/Archives/edgar/data/1847345/000149315226041918/0001493152-26-041918-index.htm", "period_of_report": "2026-09-08"}, "html_url": "/api/filings/000149315226041918/stream", "exhibits": [{"exhibit_number": "3.1", "exhibit_type": "3", "description": "Certificate of Amendment of Certificate of Incorporation dated September 8, 2026.", "filename": "ex3-1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1847345/000149315226041918/ex3-1.htm", "category": "incorporation", "incorporated_by_reference": false}, {"exhibit_number": "99.1", "exhibit_type": "99", "description": "Press Release dated September 9, 2026", "filename": "ex99-1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1847345/000149315226041918/ex99-1.htm", "category": "other", "incorporated_by_reference": false}], "sections": [], "tables": [{"table_index": 0, "table_type": "text", "caption": null, "header_text": "Delaware001-4129333-3467744"}, {"table_index": 1, "table_type": "text", "caption": null, "header_text": "\u2610Written\n communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)"}, {"table_index": 2, "table_type": "text", "caption": null, "header_text": "Title\n of each classTrading\n Symbol(s)Name\n of each exchange on which registered"}, {"table_index": 5, "table_type": "exhibit_index", "caption": null, "header_text": "Exhibit\n No.Description"}, {"table_index": 8, "table_type": "text", "caption": null, "header_text": "ASPIRE\n BIOPHARMA HOLDINGS, INC."}], "exhibits_pending": false, "cdn_html": true, "response_time_ms": 28}